Japan approves Forxiga to treat chronic kidney disease in patients with and without type-II diabetes
Forxiga is the first-ever approved medicine for the treatment of the disease in Japan
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Forxiga
Astrazeneca’s Dapagliflozin gets DCGI nod for treatment of heart failure
Dapagliflozin (Forxiga) is an SGLT-2 inhibitor that can reduce the risk of cardiovascular death and hospitalisation for heart…
AstraZeneca Pharma launches Forxiga in India
Forxiga is indicated to be used as an adjunct to diet and exercise in combination with other glucose-lowering medicinal products,…